Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INNOVATION: Telmisartan in Diabetic Nephropathy
NCT00153088Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2003
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of telmisartan in diabetic nephropathy (DN) (3 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Transition from incipient to overt nephropathy. Started Jan 2003; status: completed.
02
Drugs
telmisartan
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00153088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00153088.